Novartis AG is 1.3x more valuable than GSK plc by market capitalization ($283.13 B vs $221.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GSK | NVS |
|---|---|---|
| Market cap | $221.53 B | $283.13 B |
| US-listed rank | #62 | #47 |
| SEC filings | 988 | 947 |
Novartis AG is 1.3x more valuable than GSK plc by market capitalization ($283.13 B vs $221.53 B).
Full pages: GSK plc and Novartis AG, or browse the full rankings.